BE-Brussel-BORDET

Brussels

2 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia, Acute Myeloid Leukemia, Adult

Studies at this site

• Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML) — Recruiting now
• Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML — Recruiting now